How FDA Differs From CMS In Clinical Lab Test Oversight
The U.S. Food and Drug Administration has previously announced an interest in regulating diagnostic tests used in providing personalized medicine clinical care. Interested stakeholders such as the American Clinical Laboratory Association,...To view the full article, register now.
Already a subscriber? Click here to view full article